T
32
2
PEP
33
4
TXT
46
4
KIM
58
2
ZBH
69
15
BDX
59
3
EXPE
83
8
CTSH
55
3
VMC
41
2
VRSK
54
2
AEP
45
5
EA
41
3
HBAN
47
7
MCD
52
3
ADT
12
2
INTU
54
2
ECL
54
5
FITB
36
3
CAG
34
3
DIS
70
2
T
32
2
PEP
33
4
TXT
46
4
KIM
58
2
ZBH
69
15
BDX
59
3
EXPE
83
8
CTSH
55
3
VMC
41
2
VRSK
54
2
AEP
45
5
EA
41
3
HBAN
47
7
MCD
52
3
ADT
12
2
INTU
54
2
ECL
54
5
FITB
36
3
CAG
34
3
DIS
70
2
Financhill
Back

Entrada Therapeutics Vs. Nukkleus Industry Stock Comparison

Sell
37

TRDA
Entrada Therapeutics

Last Price:
$17.60
Seasonality Move:
-24.47%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
37
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $17.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 41.98 Sell
Chaikin Money Flow: 106552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.67 - 20.29) Sell
Bollinger Bands (100): (15.2 - 18.88) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.02 Sell
20-day SMA: 19.27 Sell
50-day SMA: 18.48 Sell
200-day SMA: 15.77 Buy
8-day EMA: 18.11 Sell
20-day EMA: 18.7 Sell
50-day EMA: 18.33 Sell
200-day EMA: 16.47 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):